MUC16 as a serum-based prognostic indicator of prometastatic gastric cancer
Authors:
Open Access
- 2 July 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Abstract
Metastatic gastric cancer (GC) presents significant clinical challenges due to its poor prognosis and limited treatment options. To address this, we conducted a targeted protein biomarker discovery study to identify markers predictive of metastasis in advanced GC (AGC). Serum samples from 176 AGC patients (T stage 3 or higher) were analyzed using the Olink Proteomics Target panels. Patients were retrospectively categorized into nonmetastatic, metastatic, and recurrence groups, and differential protein expression was assessed. Machine learning and gene set enrichment analysis (GSEA) methods were applied to discover biomarkers and predict prognosis. Four proteins (MUC16, CAIX, 5’-NT, and CD8A) were significantly elevated in metastatic GC patients compared to the control group. Additionally, GSEA indicated that the response to interleukin-4 and hypoxia-related pathways were enriched in metastatic patients. Random forest classification and decision-tree modeling showed that MUC16 could be a predictive marker for metastasis in GC patients. Additionally, ELISA validation confirmed elevated MUC16 levels in metastatic patients. Notably, high MUC16 levels were independently associated with metastatic progression in T3 or higher GC. These findings suggest the potential of MUC16 as a clinically relevant biomarker for identifying GC patients at high risk of metastasis.Keywords
Funding Information
- Ministry of Trade, Industry and Energy and the Ministry of SMEs and Startups of the Republic of Korea (S2638360)
- National Research Foundation of Korea (2021R1A2C1013554)
This publication has 31 references indexed in Scilit:
- Next generation pan-cancer blood proteome profiling using proximity extension assayNature Communications, 2023
- Decision tree based ensemble machine learning model for the prediction of Zika virus T-cell epitopes as potential vaccine candidatesScientific Reports, 2022
- Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challengesBiomedicine & Pharmacotherapy, 2022
- Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein ProfilingJournal of Proteome Research, 2020
- Carbonic anhydrase IX and acid transport in cancerBritish Journal of Cancer, 2019
- Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational studyGastric Cancer, 2019
- MUC16 as a novel target for cancer therapyExpert Opinion on Therapeutic Targets, 2018
- Parallel Protein Detection by Solid‐Phase Proximity Ligation Assay with Real‐Time PCR or SequencingCurrent Protocols in Molecular Biology, 2015
- Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancerTumor Biology, 2013
- Carbonic Anhydrase IX: Regulation and Role in Cancer2013